Insmed (INSM) Interest Expenses (2011 - 2026)

For the trailing twelve months through Jun 30, 2026, Interest Expenses at Insmed was $81.34 million, down 4.8% year-over-year; for FY2025, it came in at $83.8 million, down 1.3% from FY2024.

• Annual Interest Expenses shows a five-year compound annual growth rate of 23.2% (FY2020 to FY2025).
• In prior years, Insmed's Interest Expenses was $84.91 million in FY2024 (+3.9%), $81.69 million in FY2023 (+208.9%), $26.45 million in FY2022 (-34.7%) and $40.47 million in FY2021 (+36.9%).
• Quarterly Interest Expenses has run from a low of $3.29 million in Q1 2022 to a high of $21.57 million in Q1 2025 over five years.
• On a year-over-year basis, Interest Expenses has declined in each of the last five quarters, with an average decline of 1.2% over the last eight quarters.
• The strongest year-over-year quarter for Interest Expenses in the past five years was Q2 2023, with growth of 514.2%; the weakest was Q3 2022, with a decline of 70.2%.
• According to Business Quant data, Interest Expenses for the three prior quarters was $20.08 million (Q1 2026), $20.6 million (Q4 2025) and $20.38 million (Q3 2025).